Released on: January 7, 2008, 10:46 am

Press Release Author: GTCBIO

Industry: Pharmaceuticals

Press Release Summary: MONROVIA, CA - Susanta K. Sarkar, Director of the Molecular
Imaging Center of Excellence at GlaxoSmithKline will speak at GTCbio's 3rd Imaging
in Drug Development conference on March 17-18, 2008 in San Diego.

Press Release Body: Director, Molecular Imaging at GSK to speak at 3rd Imaging in
Drug Development conference March 2008


FOR IMMEDIATE RELEASE
December 20, 2007

MONROVIA, CA - Susanta K. Sarkar, Director of the Molecular Imaging Center of
Excellence at GlaxoSmithKline will speak at GTCbio's 3rd Imaging in Drug Development
conference on March 17-18, 2008 in San Diego.

Dr. Sarkar will present on molecular imaging approaches to in vivo pharmacokinetic
and pharmacodynamic studies: a pharmaceutical prospective.

A major challenge facing the pharmaceutical industry today is the high attrition of
drugs. This is, in large part, due to efficacies that are lower than expected from
pre-clinical and clinical studies, and from side effects that are higher than
expected in these studies. It is critical, therefore, to measure PK/PD relationship
of compounds from target and pathways specific measurements in vivo early in
preclinical drug discovery and development to increase the predictive values of
preclinical studies. Multi-modal molecular imaging technologies promise to be a
powerful approach towards addressing these issues.

Towards this end, Dr. Sarkar's talk will emphasize the development of multi-modal
imaging methodologies to measure efficacy, safety, mechanism of action and
distribution of compounds in live animals and in real time across many therapeutic
areas.

Potential translation of these methodologies to clinical studies will also be
discussed.

The 3rd Imaging in Pre-clinical & Clinical Drug Development conference features
presentations on novel imaging methods and technology, imaging in drug development
and therapy, imaging applications in CNS, imaging applications in oncology and
imaging applications in the cardiovascular system. For more information, visit
www.gtcbio.com.


ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, customerservices@gtcbio.com



Web Site: http://

Contact Details: Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
customerservices@gtcbio.com